David E. Neal

Molecular Biology · 2008–2018

A researcher in the Science corpus: 13 papers; trusts 6 researchers and is trusted by 8 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 147 citations into it; #4,565 of 17,773 by trust here, #2,983 by citations

Whom David E. Neal trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Ryuji Hamamoto
2. Yusuke Nakamura
3. Helen I. Field
4. S. Hayami
5. Masanori Yoshimatsu
6. Bruce A. J. Ponder

Who trusts David E. Neal overall

1. Hyun-soo Cho

Papers from David E. Neal's perspective

Ordered by how strongly the researchers David E. Neal trusts endorse each paper. Same corpus, a different order for every researcher.

1. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins (Nature)
2. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain (Nature)
3. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. (Cell)
4. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells
5. SET Domain-containing Protein, G9a, Is a Novel Lysine-preferring Mammalian Histone Methyltransferase with Hyperactivity and Specific Selectivity to Lysines 9 and 27 of Histone H3* (Journal of Biological Chemistry)
6. The language of covalent histone modifications (Nature)
7. Regulation of chromatin structure by site-specific histone H3 methyltransferases (Nature)
8. MLL translocations, histone modifications and leukaemia stem-cell development (Nature Reviews. Cancer)
9. Genome-wide map of nucleosome acetylation and methylation in yeast. (Cell)
10. Caught up in a Wnt storm: Wnt signaling in cancer. (Biochimica et Biophysica Acta)

Their papers

• Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers (2011) — 455 citations
• Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway (2010) — 222 citations
• Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer (2011) — 114 citations
• Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1. (2011) — 120 citations
• RB1 methylation by SMYD2 enhances cell cycle progression through an increase of RB1 phosphorylation. (2012) — 196 citations
• Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway. (2011) — 100 citations
• The Histone Demethylase JMJD2B Plays an Essential Role in Human Carcinogenesis through Positive Regulation of Cyclin-Dependent Kinase 6 (2011) — 68 citations
• The histone methyltransferase Wolf–Hirschhorn syndrome candidate 1‐like 1 (WHSC1L1) is involved in human carcinogenesis (2013) — 67 citations
• Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2018) — 797 citations
• The Evolutionary History of Lethal Metastatic Prostate Cancer (2015) — 1,348 citations
• The JmjC domain‐containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene (2012) — 96 citations
• The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis (2011) — 624 citations
• Multiple newly identified loci associated with prostate cancer susceptibility (2008) — 884 citations